NORTHERN TRUST CORP - ALDER BIOPHARMACEUTICALS INC ownership

ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 141 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 2.67 and the average weighting 0.2%.

Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of ALDER BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q3 2019$17,424,000
+89.3%
923,900
+18.2%
0.00%
+100.0%
Q2 2019$9,203,000
-10.1%
781,822
+4.2%
0.00%
-33.3%
Q1 2019$10,237,000
+42.4%
750,028
+6.9%
0.00%
+50.0%
Q4 2018$7,189,000
-39.2%
701,469
-1.3%
0.00%
-33.3%
Q3 2018$11,829,000
+7.0%
710,442
+1.6%
0.00%0.0%
Q2 2018$11,050,000
+23.4%
699,356
-0.8%
0.00%
+50.0%
Q1 2018$8,952,000
+11.3%
704,849
+0.3%
0.00%0.0%
Q4 2017$8,045,000
-10.0%
702,604
-3.7%
0.00%0.0%
Q3 2017$8,937,000
+37.1%
729,527
+28.1%
0.00%0.0%
Q2 2017$6,518,000
-43.8%
569,291
+2.1%
0.00%
-33.3%
Q1 2017$11,600,000
+0.9%
557,747
+1.0%
0.00%
-25.0%
Q4 2016$11,492,000
-36.1%
552,488
+0.6%
0.00%
-33.3%
Q3 2016$17,996,000
+29.3%
549,157
-1.4%
0.01%
+20.0%
Q2 2016$13,913,000
+112.1%
557,214
+108.0%
0.01%
+150.0%
Q1 2016$6,560,000
-24.5%
267,827
+1.9%
0.00%
-33.3%
Q4 2015$8,686,000
+3.9%
262,957
+3.1%
0.00%0.0%
Q3 2015$8,357,000
+22.5%
255,063
+98.0%
0.00%
+50.0%
Q2 2015$6,824,000
+108.4%
128,815
+13.5%
0.00%
+100.0%
Q1 2015$3,274,000
+34.2%
113,476
+35.3%
0.00%0.0%
Q4 2014$2,440,000
+124.7%
83,885
-2.0%
0.00%
Q3 2014$1,086,000
+72.9%
85,633
+173.4%
0.00%
Q2 2014$628,00031,3200.00%
Other shareholders
ALDER BIOPHARMACEUTICALS INC shareholders Q4 2017
NameSharesValueWeighting ↓
Novo Holdings A/S 3,201,183$40,591,0003.96%
Cormorant Asset Management, LP 150,000$1,902,0000.39%
PFM Health Sciences, LP 1,034,030$13,112,0000.30%
Partner Investment Management, L.P. 23,660$300,0000.11%
PointState Capital LP 375,000$4,755,0000.09%
Spark Investment Management LLC 38,400$486,0000.07%
SECTORAL ASSET MANAGEMENT INC 89,300$1,132,0000.05%
DRIEHAUS CAPITAL MANAGEMENT LLC 95,722$1,214,0000.05%
CADIAN CAPITAL MANAGEMENT, LP 120,000$1,522,0000.04%
Nicholas Investment Partners, LP 49,341$626,0000.04%
View complete list of ALDER BIOPHARMACEUTICALS INC shareholders